Literature DB >> 7858367

Post-herpetic neuralgia in older patients. Incidence and optimal treatment.

D Bowsher1.   

Abstract

Post-herpetic neuralgia (PHN) is a disease caused by having had herpes zoster; it is not a continuation of shingles. Up to 50% of elderly patients who have had shingles may develop PHN. PHN is defined as pain recurring or continuing at the site of shingles, 1 or more months after the onset of the rash. Because many cases resolve spontaneously in the early stages, no claims of 'pharmacological cure' can be entertained before 3 months post-rash. In fact, some authorities will not accept claims made before 6 months. Antivirals administered systemically within the appropriate time-window greatly relieve the pain of acute shingles, and to a large extent prevent scarring. There is no evidence that they prevent the subsequent development of PHN. However, patients with PHN whose acute shingles were treated with aciclovir obtain pain relief with antidepressants in half the time required by those patients who did not receive aciclovir for their acute shingles. If patients with acute shingles are given low dose amitriptyline from the onset, only half as many are in pain at 6 months as a group not so treated, irrespective of the antiviral treatments given. The most effective treatment of established PHN to date consists of adrenergically active antidepressants. There is a strict correlation with the brevity of the interval between acute shingles and initiation of such treatment. 75% of patients starting treatment with antidepressants within 3 to 6 months after shingles obtain pain relief, whereas if antidepressants are not started for 2 years, only 25% obtain pain relief.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7858367     DOI: 10.2165/00002512-199405060-00003

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  22 in total

1.  THE NATURE OF HERPES ZOSTER: A LONG-TERM STUDY AND A NEW HYPOTHESIS.

Authors:  R E HOPE-SIMPSON
Journal:  Proc R Soc Med       Date:  1965-01

2.  The prognosis with postherpetic neuralgia.

Authors:  Peter N C Watson; Verna R Watt; Mary Chipman; Nicholas Birkett; Ramon J Evans
Journal:  Pain       Date:  1991-08       Impact factor: 6.961

3.  EMLA cream in the treatment of post-herpetic neuralgia. Efficacy and pharmacokinetic profile.

Authors:  Peter J Stow; Chris J Glynn; Bruce Minor
Journal:  Pain       Date:  1989-12       Impact factor: 6.961

4.  Lack of effect of acyclovir on postherpetic neuralgia.

Authors:  M W McKendrick; J I McGill; M J Wood
Journal:  BMJ       Date:  1989-02-18

5.  Concerning the management of pain associated with herpes zoster and of postherpetic neuralgia.

Authors:  Robert B King
Journal:  Pain       Date:  1988-04       Impact factor: 6.961

6.  Treatment of post-herpetic neuralgia.

Authors:  J M Woodforde; B Dwyer; B W McEwen; F W De Wilde; K Bleasel; T J Connelley; C Y Ho
Journal:  Med J Aust       Date:  1965-11-20       Impact factor: 7.738

7.  Post-herpetic neuralgia: further post-mortem studies of cases with and without pain.

Authors:  C P N Watson; J H Deck; C Morshead; D Van der Kooy; R J Evans
Journal:  Pain       Date:  1991-02       Impact factor: 6.961

8.  Epidemiology of herpes zoster in children and adolescents: a population-based study.

Authors:  H A Guess; D D Broughton; L J Melton; L T Kurland
Journal:  Pediatrics       Date:  1985-10       Impact factor: 7.124

9.  Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain.

Authors:  S Arnér; B A Meyerson
Journal:  Pain       Date:  1988-04       Impact factor: 6.961

10.  Acute herpes zoster and postherpetic neuralgia: effects of acyclovir and outcome of treatment with amitriptyline.

Authors:  D Bowsher
Journal:  Br J Gen Pract       Date:  1992-06       Impact factor: 5.386

View more
  6 in total

Review 1.  The management of postherpetic neuralgia.

Authors:  D Bowsher
Journal:  Postgrad Med J       Date:  1997-10       Impact factor: 2.401

Review 2.  Topical capsaicin. A review of its pharmacological properties and therapeutic potential in post-herpetic neuralgia, diabetic neuropathy and osteoarthritis.

Authors:  C Rains; H M Bryson
Journal:  Drugs Aging       Date:  1995-10       Impact factor: 3.923

Review 3.  Amitriptyline. A review of its pharmacological properties and therapeutic use in chronic pain states.

Authors:  H M Bryson; M I Wilde
Journal:  Drugs Aging       Date:  1996-06       Impact factor: 3.923

4.  Ramsay-Hunt syndrome complicating osteonecrosis of edentulous maxilla and mandible: report of a rare case.

Authors:  Samprati J Badjate; K M Cariappa; S R Shenoi; Shweta Nakhate
Journal:  J Maxillofac Oral Surg       Date:  2009-08-11

5.  A prognostic score for postherpetic neuralgia in ambulatory patients.

Authors:  W Meister; A Neiss; G Gross; H W Doerr; W Höbel; J P Malin; J von Essen; B Y Reimann; C Witke; P Wutzler
Journal:  Infection       Date:  1998 Nov-Dec       Impact factor: 7.455

6.  Prevention of shingles: safety and efficacy of live zoster vaccine.

Authors:  Dianna Quan; Randall J Cohrs; Ravi Mahalingam; Donald H Gilden
Journal:  Ther Clin Risk Manag       Date:  2007-08       Impact factor: 2.423

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.